JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 22 August 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.00702-07v1
81/21/11620    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wathelet, M. G.
Right arrow Articles by Baric, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wathelet, M. G.
Right arrow Articles by Baric, R. S.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.00702-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The SARS coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain

Marc G. Wathelet*, Melissa Orr, Matthew B. Frieman, and Ralph S. Baric

Department of Molecular and Cellular Physiology, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH45267-0576, U.S.A.; Departments of Epidemiology and Microbiology and Immunology and; Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599-7435, U.S.A.

* To whom correspondence should be addressed. Email: marc.wathelet{at}uc.edu.


   Abstract

The severe acute respiratory syndrome (SARS) epidemic was caused by the spread of a previously unrecognized infectious agent, the SARS-associated coronavirus (SARS-CoV). Here we show that SARS-CoV could inhibit both virus- and interferon (IFN)-dependent signaling, two key steps of the antiviral response. We mapped a strong inhibitory activity to SARS-CoV non-structural protein 1 (nsp1) and show that expression of nsp1 significantly inhibited the activation of all three virus-dependent signaling pathways. We show that expression of nsp1 significantly inhibited IFN-dependent signaling by decreasing the phosphorylation levels of STAT1, while having little effect on those of STAT2, JAK1 and TYK2. We engineered an attenuated mutant of nsp1 in SARS-CoV through reverse genetics and the resulting mutant virus was viable and replicated as efficiently as wild type virus in cells with a defective IFN response. However, the mutant virus replication was strongly attenuated in cells with an intact IFN response. Thus, nsp1 is likely a virulence factor that would contribute to pathogenicity by favoring SARS-CoV replication.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.